News
The pharmaceutical industry has long protested the idea of globally linked drug prices as a threat to years of U.S. dominance ...
Trade deficit data, Federal Reserve officials' remarks, earnings from Pfizer, Disney, Uber, and additional companies.
The pharmaceutical industry continues to evolve rapidly, driven by innovation, global health challenges, and technological ...
President Donald Trump just sent letters to heads of 17 major pharmaceutical companies pushing them to drop drug prices in ...
The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...
State Medicaid programs already are allowed to offer GLP-1 drugs for weight loss, but only 13 state programs currently do so. Meanwhile, Medicare currently covers GLP-1 drugs for people with a ...
3 Minute Breakdowns on MSN1d
novo nordisk stock analysis: ozempic, wegovy, and market share - august 2025
Is Novo Nordisk stock a buy? An analysis of $NVO, its weight loss drugs Ozempic and Wegovy, and market share competition with ...
HYDERABAD — Dr Reddy’s Laboratories is gearing up to enter the booming global obesity drug market with a more affordable ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.
Trump sent the request to 17 companies, including Sanofi, AstraZeneca, GSK, Merck KGaA and Novo Nordisk from the European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results